Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa

Yi Zhen Ng, Celine Pourreyron, Julio C. Salas-Alanis, Jasbani H.S. Dayal, Rodrigo Cepeda-Valdes, Wenfei Yan, Sheila Wright, Mei Chen, Jo David Fine, Fiona J. Hogg, John A. McGrath, Dedee F. Murrell, Irene M. Leigh, E. Birgit Lane, Andrew P. South

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Patients with the genetic skin blistering disease recessive dystrophic epidermolysis bullosa (RDEB) develop aggressive cutaneous squamous cell carcinoma (cSCC). Metastasis leading to mortality is greater in RDEB than in other patient groups with cSCC. Here we investigate the dermal component in RDEB using mRNA expression profiling to compare cultured fibroblasts isolated from individuals without cSCC and directly from tumor matrix in RDEB and non-RDEB samples. Although gene expression of RDEB normal skin fibroblasts resembled that of cancer-associated fibroblasts, RDEB cancer-associated fibroblasts exhibited a distinct and divergent gene expression profile, with a large proportion of the differentially expressed genes involved in matrix and cell adhesion. RDEB cancer-associated fibroblasts conferred increased adhesion and invasion to tumor and non-tumor keratinocytes. Reduction of COL7A1, the defective gene in RDEB, in normal dermal fibroblasts led to increased type XII collagen, thrombospondin-1, and Wnt-5A, while reexpression of wild type COL7A1 in RDEB fibroblasts decreased type XII collagen, thrombospondin-1, and Wnt-5A expression, reduced tumor cell invasion in organotypic culture, and restricted tumor growth in vivo. Overall, our findings show that matrix composition in patients with RDEB is a permissive environment for tumor development, and type VII collagen directly regulates the composition of matrix proteins secreted by dermal and cancer-associated fibroblasts. ©2012 AACR.
Original languageEnglish
Pages (from-to)3522-3534
Number of pages13
JournalCancer Research
DOIs
Publication statusPublished - 15 Jul 2012
Externally publishedYes

Fingerprint

Epidermolysis Bullosa Dystrophica
Squamous Cell Carcinoma
Fibroblasts
Skin
Collagen Type XII
Thrombospondin 1
Neoplasms
Genetic Skin Diseases
Collagen Type VII
Cell-Matrix Junctions
Recessive Genes
Skin Neoplasms
Keratinocytes
Transcriptome

Cite this

Ng, Yi Zhen ; Pourreyron, Celine ; Salas-Alanis, Julio C. ; Dayal, Jasbani H.S. ; Cepeda-Valdes, Rodrigo ; Yan, Wenfei ; Wright, Sheila ; Chen, Mei ; Fine, Jo David ; Hogg, Fiona J. ; McGrath, John A. ; Murrell, Dedee F. ; Leigh, Irene M. ; Lane, E. Birgit ; South, Andrew P. / Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa. In: Cancer Research. 2012 ; pp. 3522-3534.
@article{31367d254c40488dbdffec336b98c10a,
title = "Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa",
abstract = "Patients with the genetic skin blistering disease recessive dystrophic epidermolysis bullosa (RDEB) develop aggressive cutaneous squamous cell carcinoma (cSCC). Metastasis leading to mortality is greater in RDEB than in other patient groups with cSCC. Here we investigate the dermal component in RDEB using mRNA expression profiling to compare cultured fibroblasts isolated from individuals without cSCC and directly from tumor matrix in RDEB and non-RDEB samples. Although gene expression of RDEB normal skin fibroblasts resembled that of cancer-associated fibroblasts, RDEB cancer-associated fibroblasts exhibited a distinct and divergent gene expression profile, with a large proportion of the differentially expressed genes involved in matrix and cell adhesion. RDEB cancer-associated fibroblasts conferred increased adhesion and invasion to tumor and non-tumor keratinocytes. Reduction of COL7A1, the defective gene in RDEB, in normal dermal fibroblasts led to increased type XII collagen, thrombospondin-1, and Wnt-5A, while reexpression of wild type COL7A1 in RDEB fibroblasts decreased type XII collagen, thrombospondin-1, and Wnt-5A expression, reduced tumor cell invasion in organotypic culture, and restricted tumor growth in vivo. Overall, our findings show that matrix composition in patients with RDEB is a permissive environment for tumor development, and type VII collagen directly regulates the composition of matrix proteins secreted by dermal and cancer-associated fibroblasts. {\circledC}2012 AACR.",
author = "Ng, {Yi Zhen} and Celine Pourreyron and Salas-Alanis, {Julio C.} and Dayal, {Jasbani H.S.} and Rodrigo Cepeda-Valdes and Wenfei Yan and Sheila Wright and Mei Chen and Fine, {Jo David} and Hogg, {Fiona J.} and McGrath, {John A.} and Murrell, {Dedee F.} and Leigh, {Irene M.} and Lane, {E. Birgit} and South, {Andrew P.}",
year = "2012",
month = "7",
day = "15",
doi = "10.1158/0008-5472.CAN-11-2996",
language = "English",
pages = "3522--3534",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",

}

Ng, YZ, Pourreyron, C, Salas-Alanis, JC, Dayal, JHS, Cepeda-Valdes, R, Yan, W, Wright, S, Chen, M, Fine, JD, Hogg, FJ, McGrath, JA, Murrell, DF, Leigh, IM, Lane, EB & South, AP 2012, 'Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa', Cancer Research, pp. 3522-3534. https://doi.org/10.1158/0008-5472.CAN-11-2996

Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa. / Ng, Yi Zhen; Pourreyron, Celine; Salas-Alanis, Julio C.; Dayal, Jasbani H.S.; Cepeda-Valdes, Rodrigo; Yan, Wenfei; Wright, Sheila; Chen, Mei; Fine, Jo David; Hogg, Fiona J.; McGrath, John A.; Murrell, Dedee F.; Leigh, Irene M.; Lane, E. Birgit; South, Andrew P.

In: Cancer Research, 15.07.2012, p. 3522-3534.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Fibroblast-derived dermal matrix drives development of aggressive cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa

AU - Ng, Yi Zhen

AU - Pourreyron, Celine

AU - Salas-Alanis, Julio C.

AU - Dayal, Jasbani H.S.

AU - Cepeda-Valdes, Rodrigo

AU - Yan, Wenfei

AU - Wright, Sheila

AU - Chen, Mei

AU - Fine, Jo David

AU - Hogg, Fiona J.

AU - McGrath, John A.

AU - Murrell, Dedee F.

AU - Leigh, Irene M.

AU - Lane, E. Birgit

AU - South, Andrew P.

PY - 2012/7/15

Y1 - 2012/7/15

N2 - Patients with the genetic skin blistering disease recessive dystrophic epidermolysis bullosa (RDEB) develop aggressive cutaneous squamous cell carcinoma (cSCC). Metastasis leading to mortality is greater in RDEB than in other patient groups with cSCC. Here we investigate the dermal component in RDEB using mRNA expression profiling to compare cultured fibroblasts isolated from individuals without cSCC and directly from tumor matrix in RDEB and non-RDEB samples. Although gene expression of RDEB normal skin fibroblasts resembled that of cancer-associated fibroblasts, RDEB cancer-associated fibroblasts exhibited a distinct and divergent gene expression profile, with a large proportion of the differentially expressed genes involved in matrix and cell adhesion. RDEB cancer-associated fibroblasts conferred increased adhesion and invasion to tumor and non-tumor keratinocytes. Reduction of COL7A1, the defective gene in RDEB, in normal dermal fibroblasts led to increased type XII collagen, thrombospondin-1, and Wnt-5A, while reexpression of wild type COL7A1 in RDEB fibroblasts decreased type XII collagen, thrombospondin-1, and Wnt-5A expression, reduced tumor cell invasion in organotypic culture, and restricted tumor growth in vivo. Overall, our findings show that matrix composition in patients with RDEB is a permissive environment for tumor development, and type VII collagen directly regulates the composition of matrix proteins secreted by dermal and cancer-associated fibroblasts. ©2012 AACR.

AB - Patients with the genetic skin blistering disease recessive dystrophic epidermolysis bullosa (RDEB) develop aggressive cutaneous squamous cell carcinoma (cSCC). Metastasis leading to mortality is greater in RDEB than in other patient groups with cSCC. Here we investigate the dermal component in RDEB using mRNA expression profiling to compare cultured fibroblasts isolated from individuals without cSCC and directly from tumor matrix in RDEB and non-RDEB samples. Although gene expression of RDEB normal skin fibroblasts resembled that of cancer-associated fibroblasts, RDEB cancer-associated fibroblasts exhibited a distinct and divergent gene expression profile, with a large proportion of the differentially expressed genes involved in matrix and cell adhesion. RDEB cancer-associated fibroblasts conferred increased adhesion and invasion to tumor and non-tumor keratinocytes. Reduction of COL7A1, the defective gene in RDEB, in normal dermal fibroblasts led to increased type XII collagen, thrombospondin-1, and Wnt-5A, while reexpression of wild type COL7A1 in RDEB fibroblasts decreased type XII collagen, thrombospondin-1, and Wnt-5A expression, reduced tumor cell invasion in organotypic culture, and restricted tumor growth in vivo. Overall, our findings show that matrix composition in patients with RDEB is a permissive environment for tumor development, and type VII collagen directly regulates the composition of matrix proteins secreted by dermal and cancer-associated fibroblasts. ©2012 AACR.

U2 - 10.1158/0008-5472.CAN-11-2996

DO - 10.1158/0008-5472.CAN-11-2996

M3 - Article

SP - 3522

EP - 3534

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

ER -